Top

Published in:

01-12-2009

The correlation between a family history of colorectal cancer and survival of patients with colorectal cancer

Authors: Helgi Birgisson, Arezo Ghanipour, Kennet Smedh, Lars Påhlman, Bengt Glimelius

Published in: Familial Cancer | Issue 4/2009

Abstract

The purpose was to analyze survival of patients with colorectal cancer and a positive family history for colorectal cancer in first degree relatives compared with those with no such family history and to determine whether differences in survival could be explained by known clinico-pathological factors. During 2000–2003, 318 consecutive patients with colorectal cancer answered a written questionnaire about their family history for colorectal cancer. During a 6-year follow-up, recurrences and survival were registered. Thirty-one (10%) patients had a first-degree relative with colorectal cancer, moreover two patients fulfilled the criteria of hereditary non-polyposis colorectal cancer and were excluded. Patients with a first-degree relative with colorectal cancer had better survival and lower risk for recurrences compared to those with no relatives with colorectal cancer. In a multivariate analysis including age, gender, stage of disease, tumor differentiation, vascular invasion and family history, patients with first-degree relatives with colorectal cancer had lower risks for death (RR 0.37; 95% CI 0.17–0.78) and death from cancer (RR 0.25; 95% CI 0.08–0.80), compared to those with a no relative with colorectal cancer. The differences were seen in patients with colon cancer but not rectal cancer. Family history for colorectal cancer in a first-degree relative is an individual prognostic factor in patients with colon cancer and could not be explained by known clinico-pathological factors. The value of family history taking in patients with colon cancer is therefore not only to identify families with hereditary colorectal cancer, but also to add information to the prognosis of the patients.

Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Horner MJ, Howlader N, Eisner MP, Reichman M, Edwards BK, SEER Cancer Statistics Review, 1975–2004. National Cancer Institute. Bethesda, MD. Available at: http://seer.cancer.gov/1975_2004/

Olsson L, Lindblom A (2003) Family history of colorectal cancer in a Sweden county. Fam Cancer 2(2):87–93CrossRefPubMed

Fuchs CS, Giovannucci EL, Colditz GA et al (1994) A prospective study of family history and the risk of colorectal cancer. N Engl J Med 331(25):1669–1674CrossRefPubMed

Bonelli L, Martines H, Conio M et al (1988) Family history of colorectal cancer as a risk factor for benign and malignant tumours of the large bowel. A case–control study. Int J Cancer 41(4):513–517CrossRefPubMed

Kerber RA, Slattery ML, Potter JD et al (1998) Risk of colon cancer associated with a family history of cancer or colorectal polyps: the diet, activity, and reproduction in colon cancer study. Int J Cancer 78(2):157–160CrossRefPubMed

Johns LE, Houlston RS (2001) A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 96(10):2992–3003CrossRefPubMed

Aaltonen LA, Salovaara R, Kristo P et al (1998) Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 338(21):1481–1487CrossRefPubMed

Pinol V, Andreu M, Castells A et al (2004) Frequency of hereditary non-polyposis colorectal cancer and other colorectal cancer familial forms in Spain: a multicentre, prospective, nationwide study. Eur J Gastroenterol Hepatol 16(1):39–45CrossRefPubMed

Bulow S (2003) Results of national registration of familial adenomatous polyposis. Gut 52(5):742–746CrossRefPubMed

10.

Jarvinen HJ (1992) Epidemiology of familial adenomatous polyposis in Finland: impact of family screening on the colorectal cancer rate and survival. Gut 33(3):357–360CrossRefPubMed

11.

Church J, Kiringoda R, LaGuardia L (2004) Inherited colorectal cancer registries in the United States. Dis Colon Rectum 47(5):674–678CrossRefPubMed

12.

Birgisson H, Talback M, Gunnarsson U et al (2005) Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol 31(8):845–853CrossRefPubMed

13.

Compton CC, Fielding LP, Burgart LJ et al (2000) Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124(7):979–994PubMed

14.

Zlobec I, Lugli A (2008) Prognostic and predictive factors in colorectal cancer. J Clin Pathol 61(5):561–569PubMed

15.

Clinical and pathological analyses of patients with a family history of colorectal cancer. Registry Committee, Japanese Research Society for Cancer of the Colon and Rectum. Jpn J Clin Oncol 1993 Dec; 23(6): 342–349

16.

Chan JA, Meyerhardt JA, Niedzwiecki D et al (2008) Association of family history with cancer recurrence and survival among patients with stage III colon cancer. JAMA 299(21):2515–2523CrossRefPubMed

17.

Slattery ML, Kerber RA (1995) The impact of family history of colon cancer on survival after diagnosis with colon cancer. Int J Epidemiol 24(5):888–896CrossRefPubMed

18.

Bass AJ, Meyerhardt JA, Chan JA et al (2008) Family history and survival after colorectal cancer diagnosis. Cancer 112(6):1222–1229CrossRefPubMed

19.

Zell JA, Honda J, Ziogas A et al (2008) Survival after colorectal cancer diagnosis is associated with colorectal cancer family history. Cancer Epidemiol Biomarkers Prev 17(11):3134–3140CrossRefPubMed

20.

Kune GA, Kune S, Watson LF (1992) The effect of family history of cancer, religion, parity and migrant status on survival in colorectal cancer. The Melbourne Colorectal Cancer Study. Eur J Cancer 28A(8–9):1484–1487CrossRefPubMed

21.

Kirchhoff AC, Newcomb PA, Trentham-Dietz A et al (2008) Family history and colorectal cancer survival in women. Fam Cancer 7(4):287–292CrossRefPubMed

22.

Deceased persons in Sweden 1947–2006 (2007) version 4 (CD-ROM)

23.

Vasen HF, Watson P, Mecklin JP et al (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116(6):1453–1456CrossRefPubMed

24.

Slattery ML, Mori M, Gao R et al (1995) Impact of family history of colon cancer on development of multiple primaries after diagnosis of colon cancer. Dis Colon Rectum 38(10):1053–1058CrossRefPubMed

25.

Kune GA, Kune S, Watson LF (1989) The role of heredity in the etiology of large bowel cancer: data from the Melbourne Colorectal Cancer Study. World J Surg 13(1):124–129 discussion 129-131CrossRefPubMed

26.

Dunlop MG (2002) Guidance on large bowel surveillance for people with two-first degree relatives with colorectal cancer or one-first degree relative diagnosed with colorectal cancer under 45 years. Gut 51(Suppl 5):V17–V20CrossRefPubMed

27.

Olsson L, Loof L, Ekbom A (2004) A population-based audit for diagnosing colorectal cancer. Scand J Gastroenterol 39(2):158–163CrossRefPubMed

28.

Perkovic K, Smedh K, Påhlman L (2008) Dokumentation of family history in colorectal cancer in surgical hospital records. Kirurgveckan abstract number P69 Available at URL: http://www.abstrakthantering.se/files/KV2008_abstrakt_dr.pdf

29.

Murff HJ, Spigel DR, Syngal S (2004) Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA 292(12):1480–1489CrossRefPubMed

30.

Aitken J, Bain C, Ward M et al (1995) How accurate is self-reported family history of colorectal cancer? Am J Epidemiol 141(9):863–871PubMed

31.

Olsson L, Bergkvist L, Ekbom A (2004) Symptom duration versus survival in non-emergency colorectal cancer. Scand J Gastroenterol 39(3):252–258CrossRefPubMed

32.

Popat S, Hubner R, Houlston RS (2005) Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 23(3):609–618CrossRefPubMed

33.

Gryfe R, Kim H, Hsieh ET et al (2000) Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 342(2):69–77CrossRefPubMed

34.

Lanza G, Gafa R, Santini A et al (2006) Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients. J Clin Oncol 24(15):2359–2367CrossRefPubMed

35.

Jernvall P, Makinen MJ, Karttunen TJ et al (1999) Microsatellite instability: impact on cancer progression in proximal and distal colorectal cancers. Eur J Cancer 35(2):197–201CrossRefPubMed

36.

Hemminki K, Li X, Dong C (2001) Second primary cancers after sporadic and familial colorectal cancer. Cancer Epidemiol Biomarkers Prev 10(7):793–798PubMed

Title: The correlation between a family history of colorectal cancer and survival of patients with colorectal cancer
Authors: Helgi Birgisson
Arezo Ghanipour
Kennet Smedh
Lars Påhlman
Bengt Glimelius
Publication date: 01-12-2009
Publisher: Springer Netherlands
Published in: Familial Cancer / Issue 4/2009
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI: https://doi.org/10.1007/s10689-009-9286-0

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2009

Mutation screening of VHL gene in a family with malignant bilateral pheochromocytoma: from isolated familial pheochromocytoma to von Hippel-Lindau disease

A study on MSH2 and MLH1 mutations in hereditary nonpolyposis colorectal cancer families from the Basque Country, describing four new germline mutations

Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome

Impact of 226C>T MSH2 gene mutation on cancer phenotypes in two HNPCC-associated highly-consanguineous families from Kuwait: emphasis on premarital genetic testing

Strategies for endometrial screening in the Lynch syndrome population: a patient acceptability study

Epitope-positive truncating MLH1 mutation and loss of PMS2: implications for IHC-directed genetic testing for lynch syndrome

Keynote webinar | Spotlight on antibody–drug conjugates in cancer